Importantly, all‐trans retinoic acid (ATRA) was found to promote the OTUD6B translation, suppress the tumorigenesis and metastasis of ESCC, and enhance the response of established ESCC tumors to anti‐PD‐1 immunotherapy. The gene discussed is OTUD6B; the disease is esophageal squamous cell carcinoma.